Valuation: Danaher Corporation

Market Cap 14TCr 12TCr 11TCr 10TCr 20TCr 13,33800Cr 20TCr 1,35100Cr 53TCr 6,55700Cr 53TCr 51TCr 22,59300Cr P/E 2026 *
31.5x
P/E 2027 * 26x
Enterprise Value 14TCr 12TCr 11TCr 10TCr 20TCr 13,33800Cr 20TCr 1,35100Cr 53TCr 6,55700Cr 53TCr 51TCr 22,59300Cr EV / Sales 2026 *
5.4x
EV / Sales 2027 * 4.96x
Free-Float
71.14%
Yield 2026 *
0.72%
Yield 2027 * 0.78%
Manager TitleAgeSince
Chief Executive Officer 62 01/09/2020
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Change 5-day change 1-year change 3-year change Capi.($)
-0.78%+1.02% - - 14TCr
+1.97%+2.03%+21.92%+0.83% 19TCr
+5.87%+5.27%-21.76%+26.78% 15TCr
+4.83%+2.06%-56.73%-15.69% 6.71TCr
+2.59%+3.95%+22.89%+3.15% 5.43TCr
+0.03%+2.19%-25.17%-31.30% 4.46TCr
+0.31%+1.30%+8.30%+43.25% 3.72TCr
-2.02%-3.91%+7.67%+9.53% 3.69TCr
+4.24%+4.66%-18.42%-2.34% 3.02TCr
+1.09%-0.30%-13.81%-18.74% 2.98TCr
Average +1.81%+2.58%-8.34%+1.72% 7.17TCr
Weighted average by Cap. +2.19%+3.54%-4.77%+5.04%

Financials

2026 *2027 *
Net sales 2.6TCr 2.27TCr 2.09TCr 1.94TCr 3.69TCr 2,47200Cr 3.74TCr 25TCr 9.73TCr 1,21500Cr 9.75TCr 9.54TCr 4,18700Cr 2.82TCr 2.47TCr 2.27TCr 2.11TCr 4.01TCr 2,68800Cr 4.07TCr 27TCr 11TCr 1,32100Cr 11TCr 10TCr 4,55200Cr
Net income 441.67Cr 386.11Cr 354.83Cr 330.74Cr 627.33Cr 42TCr 636.84Cr 4.26TCr 1.66TCr 21TCr 1.66TCr 1.62TCr 71TCr 534.79Cr 467.51Cr 429.64Cr 400.48Cr 759.59Cr 51TCr 771.11Cr 5.16TCr 2.01TCr 25TCr 2.01TCr 1.96TCr 86TCr
Net Debt - -
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Trader
Investor
Global
Quality
ESG MSCI
-